Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$732,794,424
+$170,463,206 QoQ
Shares Held
13,468,010
+2.7% QoQ
Ownership
5.44%
of shares outstanding
% of Portfolio
4.33%
of 13F equity value
Holder Rank
#2
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $7,178,355,833 across 25 Biotechnology names. EXEL ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,670,881 | $2,537,793,074 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
10,743,063 | $800,143,332 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $778,248,897 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
13,468,010 | $732,794,424 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
14,309,000 | $506,395,510 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
12,277,000 | $383,779,020 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,236,396 | $351,313,110 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,989,098 | $336,372,047 |
All Filings in EXEL
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-08-14 | $716,796,872 | 13,989,010 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $732,794,424 | 13,468,010 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $562,331,218 | 13,111,010 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $688,547,385 | 15,709,500 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $805,411,950 | 19,501,500 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $706,844,840 | 16,035,500 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $831,936,820 | 22,533,500 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $780,535,350 | 23,439,500 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $659,402,475 | 25,410,500 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $608,993,175 | 27,102,500 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $633,080,805 | 26,678,500 | Shares | Other | 2024-05-24 | |
| 2023-12-31 | $638,961,655 | 26,634,500 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $565,041,000 | 25,860,000 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $494,184,600 | 25,860,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $455,475,060 | 23,466,000 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $174,325,109 | 10,868,149 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $167,397,233 | 10,675,844 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $211,828,363 | 10,174,273 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $238,489,782 | 10,520,061 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $161,945,389 | 8,859,157 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $204,206,311 | 9,659,712 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $200,420,000 | 11,000,000 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $242,842,500 | 10,750,000 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $220,770,000 | 11,000,000 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $262,837,500 | 10,750,000 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $243,335,000 | 10,250,000 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $172,200,000 | 10,000,000 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||